Dev Institute Of Nuclear Medicine Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 10-12-2024
- Paid Up Capital ₹ 2.27 Cr
as on 10-12-2024
- Company Age 20 Year, 9 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 12.85 Cr
as on 10-12-2024
- Revenue -2.08%
(FY 2021)
- Profit 1.47%
(FY 2021)
- Ebitda -8.17%
(FY 2021)
- Net Worth 24.37%
(FY 2021)
- Total Assets 6.54%
(FY 2021)
About Dev Institute Of Nuclear Medicine
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.27 Cr.
The company currently has active open charges totaling ₹12.85 Cr.
Sangeeta Srivastva, Bipin Srivastava, Vihag Raman, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85110BR2004PTC010679
- Company No.
010679
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Apr 2004
- Date of AGM
31 Dec 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Patna, Bihar, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dev Institute Of Nuclear Medicine?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vihag Raman  | Director | 12-Apr-2015 | Current |
| Sangeeta Srivastva | Director | 08-Apr-2004 | Current |
| Bipin Srivastava | Director | 12-Apr-2015 | Current |
| Ravi Kumar | Director | 15-Jan-2018 | Current |
| Girish Srivastava | Director | 20-Apr-2021 | Current |
Financial Performance of Dev Institute Of Nuclear Medicine.
Dev Institute Of Nuclear Medicine Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 2.08% decrease. The company also saw a slight improvement in profitability, with a 1.47% increase in profit. The company's net worth Soared by an impressive increase of 24.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dev Institute Of Nuclear Medicine?
In 2021, Dev Institute Of Nuclear Medicine had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nuclear Imaging And Therapy LlpActive 5 years 10 monthsSangeeta Srivastva and Bipin Srivastava are mutual person
- Asrb Medical Services Private LimitedActive 6 years 11 months
Sangeeta Srivastva and Bipin Srivastava are mutual person
- Ramans Healthcare And Diagnostics Private LimitedActive 7 years 3 months
Sangeeta Srivastva, Bipin Srivastava and 1 more are mutual person
- Oceanik Buildtech And Constructions Private LimitedActive 8 years 6 months
Girish Srivastava is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Mar 2024 | ₹4.43 M | Open |
Hdfc Bank Limited Creation Date: 31 Dec 2022 | ₹2.50 M | Open |
Others Creation Date: 26 Jun 2019 | ₹4.50 Cr | Open |
How Many Employees Work at Dev Institute Of Nuclear Medicine?
Dev Institute Of Nuclear Medicine has a workforce of 11 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dev Institute Of Nuclear Medicine, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dev Institute Of Nuclear Medicine's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
